CFDA-SE (Synonyms: 5(6)Carboxyfluorescein diacetate succinimidyl ester, 5(6)-CFDA N-succinmidyl ester) |
Catalog No.GC14056 |
CFDA-SE는 세포막 투과성을 가진 카르복시세인 디아세테이트, 스크시니미딜 에스터의 전체 이름으로, 생존 가능한 세포 추적 또는 세포 증식 감지에 널리 사용되는 형광 염료입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 150347-59-4
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Protocol for Cell labeling and counting with CFDA-SE [1]: |
|
Cells were counted and stained with CFDA-SE, as follows:
This protocol only provides a guideline, and should be modified according to your specific needs. |
|
References: [1]. Urbani S, Caporale R,et,al. Use of CFDA-SE for evaluating the in vitro proliferation pattern of human mesenchymal stem cells. Cytotherapy. 2006;8(3):243-53. doi: 10.1080/14653240600735834. PMID: 16793733. |
|
Cell experiment [1]: |
|
Cell lines |
Human erythroleukaemic cell line K562, mouse lymphoma cell line YAC-1, human mammary cancer cell line MCF-7 and human melanoma cell line A375 |
Preparation method |
The 5 mM CFDA-SE stock in DMSO was diluted to different concentrations (2 μM, 3 μM, 4 μM, 5 μM, 10 μM and 20 μM) in PBS with a total volume of 1 ml. Cells were added to equal volume of CFDA-SE with different concentrations and incubated at 37 C for 5, 6, 7, 8, 10 and 15 min with agitation. |
Reaction Conditions |
1, 1.5, 2, 2.5, 5 and 10 µM CFDA-SE |
Applications |
CFDA-SE at 2.5 μM stained more than 95% of the cells on all cell lines tested, and dose-dependently increased fluorescence intensity of stained cells. The optimal concentration for K562 and YAC-1 was found to be 2.5 μM, while the optimal concentrations for A375 and MCF-7 were found to be 5 μM and 10 μM, respectively. Within the 6 h experiment period, no cytotoxicity related to CFDA-SE was observed. |
Animal experiment [2]: |
|
Animal models |
C57BL/6 mice, aged 5 ~ 8 weeks |
Preparation method |
Injected CFDA-SE into thymic lobe |
Dosage form |
The concentration of CFDA-SE is 10 μM |
Applications |
CFDA-SE, at 80 times the concentration used for in vitro labeling, was nontoxic and labeled randomly approximately 15% of thymocytes 24 h after injection. The turnover rate of labeled thymic emigrants in the lymph nodes was in the order of 21 days. Thus, CFDA-SE may serve as a powerful tool in relatively long-term migration studies. |
References: [1]: Wang XQ, Duan XM,et,al. Carboxyfluorescein diacetate succinimidyl ester fluorescent dye for cell labeling. Acta Biochim Biophys Sin (Shanghai). 2005 Jun;37(6):379-85. doi: 10.1111/j.1745-7270.2005.00051.x. PMID: 15944752. [2]: Graziano M, St-Pierre Y, et,al. The fate of thymocytes labeled in vivo with CFSE. Exp Cell Res. 1998 Apr 10;240(1):75-85. doi: 10.1006/excr.1997.3900. PMID: 9570923. |
CFDA-SE는 세포막 투과성을 가진 카르복시세인 디아세트산, 스크시니미딜 에스터의 약칭으로, 생존 가능한 세포 추적 또는 세포 증식 감지에 널리 사용되는 형광 염료입니다[1]. CFDA-SE로 표지된 세포의 형광은 매우 균일하고 안정적이며, 형광은 두 개의 후손 세포에 고르게 분배될 수 있습니다[2]. CFDA-SE는 강력한 초록색 형광을 방출할 수 있으며, Ex=494 nm, Em=521nm입니다.
인간 적혈구 백혈병 세포주 K562 및 다른 세포주에서는 모든 세포가 CFDA-SE에 의해 상대적으로 높은 형광 강도로 표시되지만, 표시의 효율성은 매우 가변적입니다. 전자밀도 소포가 표시된 세포에서 초미세 구조 수준에서 관찰됩니다. 형광 현미경으로 볼 때 전체 세포에 이산화물 라벨링이 가능합니다. 전체 세포는 6 주 동안 좋은 라벨을 유지합니다. CFDA-SE 라벨링은 비교적 쉽고, 세포에 대한 비독성이며 방사능이 아닙니다.
CFDA-SE 방법을 사용한 체외 림프구 세포 증식 분석은 아직 분류되지 않은 PID 환자의 유전학적 분석을 위한 미토젠성 T 림프구 반응 평가에 신뢰성 있고 실용적인 선택이다. 플로우 사이트메트리에서 NM이 감지될 때, FL1 검출 채널 CFDA-SE -라벨링된 세포를 채용할 수 있으며 형광 현미경도 인접한 세포를 염색하지 않고 CFDA-SE -라벨링된 세포를 관찰하는 데 사용될 수 있다.
CFDA-SE는 CD34+ 세포에 라벨링하는 데 효과적이라고 보고되었습니다. 태아 간이나 흉선에서 분리한 CD34+ 세포를 CFDA-SE로 라벨링하고 RAG-2/IL-2Rγ/ 마우스의 피하에 이식된 인간 흉선 내부에 주입했습니다. 1~4주 후, CFDA-SE 라벨은 T세포뿐만 아니라 CD123+/high CD4+CD45RA+ pDC2에서도 발견되어 CD34+ 세포가 흉선 내부에서 pDC2로 발전할 수 있다는 것을 나타내었습니다. pDC2 외에도, 세포면 마커인 CD11c, CD83 및 CD80으로 결정된 성숙한 형질을 가진 CFDA-SE 라벨의 수지상 대조 그래프내에서 양성 반응을 보인 수지상 대조 그래프내 주입된 인간 흉선 내 dendritic cell들이 발견되었습니다. 인간 흉선 이식체를 운반하는 마우스의 말단 부위에서는 pDC2가 발견되지 않았으므로, thymus 내부의 pDC2가 thymus 밖으로 이동하지 못한다는 것을 나타냅니다. C57BL/6 마우스에서는 CFDA-SE가 vitro 라벨링에 사용된 농도의 80배로 주입해도 비독성이며, 주사 후 24시간 이내에 thymocyte의 약 15%를 임의로 라벨링합니다. 라벨링된 흉선 이동세포의 회전율은 약 21일입니다. 따라서 CFDA-SE는 상대적으로 장기간 이동 연구에 강력한 도구로 사용될 수 있습니다.
References:
[1]: Chen JC, Chang ML, et,al. A kinetic study of the murine mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester labeling. J Immunol Methods. 2003 Aug;279(1-2):123-33. doi: 10.1016/s0022-1759(03)00236-9. PMID: 12969553.
[2]: Lyons AB, Blake SJ, et,al. Flow cytometric analysis of cell division by dilution of CFSE and related dyes. Curr Protoc Cytom. 2013;Chapter 9:Unit9.11. doi: 10.1002/0471142956.cy0911s64. PMID: 23546777.
[3]: Wang XQ, Duan XM, et,al. Carboxyfluorescein diacetate succinimidyl ester fluorescent dye for cell labeling. Acta Biochim Biophys Sin (Shanghai). 2005 Jun;37(6):379-85. doi: 10.1111/j.1745-7270.2005.00051.x. PMID: 15944752.
[4]: Gruber HE, Leslie KP, et,al. Optimization of 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester for labeling human intervertebral disc cells in vitro. Biotech Histochem. 2000 May;75(3):118-23. doi: 10.3109/10520290009066489. PMID: 10950173.
[5]: Azarsiz E, Karaca N, et,al. In vitro T lymphocyte proliferation by carboxyfluorescein diacetate succinimidyl ester method is helpful in diagnosing and managing primary immunodeficiencies. J Clin Lab Anal. 2018 Jan;32(1):e22216. doi: 10.1002/jcla.22216. Epub 2017 Apr 6. PMID: 28383134; PMCID: PMC6816938.
[6]: Li X, Dancausse H, et,al. Labeling Schwann cells with CFSE-an in vitro and in vivo study. J Neurosci Methods. 2003 May 30;125(1-2):83-91. doi: 10.1016/s0165-0270(03)00044-x. PMID: 12763234.
[7]: Weijer K, Uittenbogaart CH, et,al. Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo. Blood. 2002 Apr 15;99(8):2752-9. doi: 10.1182/blood.v99.8.2752. PMID: 11929763.
[8]: Graziano M, St-Pierre Y, et,al. The fate of thymocytes labeled in vivo with CFSE. Exp Cell Res. 1998 Apr 10;240(1):75-85. doi: 10.1006/excr.1997.3900. PMID: 9570923.
Cas No. | 150347-59-4 | SDF | |
Synonyms | 5(6)Carboxyfluorescein diacetate succinimidyl ester, 5(6)-CFDA N-succinmidyl ester | ||
Chemical Name | 5-(((2,5-dioxopyrrolidin-1-yl)oxy)carbonyl)-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl diacetate | ||
Canonical SMILES | O=C1N(OC(C2=CC=C(C3(C(C=CC(OC(C)=O)=C4)=C4OC5=C3C=CC(OC(C)=O)=C5)OC6=O)C6=C2)=O)C(CC1)=O | ||
Formula | C29H19NO11 | M.Wt | 557.46 |
Solubility | ≥ 37.2mg/mL in DMSO with ultrasonic | Storage | Store at -20°C, protect from light |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Prepare stock solution | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.7939 mL | 8.9693 mL | 17.9385 mL |
5 mM | 0.3588 mL | 1.7939 mL | 3.5877 mL |
10 mM | 0.1794 mL | 0.8969 mL | 1.7939 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Average Rating: 5
(Based on Reviews and 20 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *